
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
News

ISMP Posts COVID-19 Medication Safety Resource Page
ISMP has developed an online resource page with links to vital COVID-19 safety-related information and tools.
Read moreNews

ISMP Second Newsletter Special Edition Focuses on Infusion Pump Extension Sets to Conserve PPE
Second special edition of the ISMP Medication Safety Alert!® acute care newsletter explores the use of extension sets to position infusion pumps outside COVID-19 patients’ rooms.
Read morePress Coverage

ISMP Launches COVID-19 Safety Alerts
This article appeared on the Infectious Disease Special Edition website on March 31, 2020.
Read moreNews

ISMP Moves to Newsletter Special Editions on COVID-19 Safety Issues
During the COVID-19 pandemic, ISMP is moving to special editions of the ISMP Medication Safety Alert! acute care newsletter that will focus only on information healthcare practitioners may find use...
Read morePress Coverage

Medical Cannabis Product Labeling Could Increase Med Errors
This article appeared on the Clinical Oncology News website on March 17, 2020.
Read moreNews

ISMP Awarded Contract to Conduct Perioperative Medication Safety Self Assessment
ISMP has been awarded a contract from the U.S. Food and Drug Administration to assess medication safety practices in the perioperative setting, from the time a patient is prepared for a procedure u...
Read moreStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
Read more
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
Read more